Granulocyte colony-stimulating factor activating HIF-1α acts synergistically with erythropoietin to promote tissue plasticity

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Liu, Shih Ping ^a,b   Lee, Shin Da ^b,c   Lee, Hsu Tung ^d   Liu, Demeral David ^a   Wang, Hsiao Jung ^a   Liu, Ren Shyan ^e   Lin, Shinn Zong ^a,b   Shyu, Woei Cherng ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN BCL 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL HOMING; CELL SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LIMB ISCHEMIA; LOW DRUG DOSE; MONOTHERAPY; MOUSE; NERVE CELL PLASTICITY; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; DRUG COMBINATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; ISCHEMIA; METABOLISM; PHYSIOLOGY; PROMOTER REGION; STEM CELL;

ANIMALIA; MUS;

ANIMALS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; STEM CELLS;

EID: 77956319600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010093     Document Type: Article

References (52)

1. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35: 1732-1737.
2. Signore AP, Weng Z, Hastings T, Van Laar AD, Liang Q, et al. (2006) Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death. J Neurochem 96: 428-443.
3. Frampton JE, Lee CR, Faulds D (1994) Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48: 731-760.
4. Lee ST, Chu K, Jung KH, Ko SY, Kim EH, et al. (2005) Granulocyte colonystimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 1058: 120-128.
5. Park HK, Chu K, Lee ST, Jung KH, Kim EH, et al. (2005) Granulocyte colonystimulating factor induces sensorimotor recovery in intracerebral hemorrhage. Brain Res 1041: 125-131.
6. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, et al. (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115: 2083-2098.
7. Wenger RH (2000) Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 203: 1253-1263.
8. Dery MA, Michaud MD, Richard DE (2005) Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37:535-540.
9. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W (1999) Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94: 1561-1567.
10. Richard DE, Berra E, Pouyssegur J (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275: 26765-26771.
11. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, et al. (2001) Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 89: 47-54.
12. Doronzo G, Russo I, Mattiello L, Riganti C, Anfossi G, et al. (2006) Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling. Diabetologia 49: 1049-1063.
13. de Haan G, Engel C, Dontje B, Nijhof W, Loeffler M (1994) Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: in vivo interactions and dose-response surfaces. Blood 84:4157-4163.
14. Roeder I, de Haan G, Engel C, Nijhof W, Dontje B, et al. (1998) Interactions of erythropoietin, granulocyte colony-stimulating factor, stem cell factor, and interleukin-11 on murine hematopoiesis during simultaneous administration. Blood 91: 3222-3229.
15. Ulich TR, del Castillo J, McNiece IK, Yi ES, Alzona CP, et al. (1991) Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo.Blood 78: 1954-1962.
16. Casadevall N, Durieux P, Dubois S, Hemery F, Lepage E, et al. (2004) Health, economic, and quality-of-life effects of erythropoietin and granulocyte colonystimulating factor for the treatment of myelodysplastic syndromes: a randomized,controlled trial. Blood 104: 321-327.
17. Pierelli L, Perillo A, Greggi S, Salerno G, Panici PB, et al. (1999) Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. J Clin Oncol 17: 1288.
18. Balleari E, Rossi E, Clavio M, Congiu A, Gobbi M, et al. (2006) Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study. Ann Hematol 85: 174-180.
19. Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, et al. (2004) Functional recovery of stroke rats induced by granulocyte colony-stimulating factorstimulated stem cells. Circulation 110: 1847-1854.
20. Spandou E, Papadopoulou Z, Soubasi V, Karkavelas G, Simeonidou C, et al. (2005) Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 1045: 22-30.
21. Wei L, Han BH, Li Y, Keogh CL, Holtzman DM, et al. (2006) Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 317: 109-116.
22. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, et al. (2006) Cytokinemediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12: 557-567.
23. Jung KH, Chu K, Lee ST, Kim SJ, Sinn DI, et al. (2006) Granulocyte colonystimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Res 1073-1074: 190-201.
24. Pi X, Garin G, Xie L, Zheng Q, Wei H, et al. (2005) BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha. Circ Res 96: 1145-1151.
25. Shams I, Nevo E, Avivi A (2005) Ontogenetic expression of erythropoietin and hypoxia-inducible factor-1 alpha genes in subterranean blind mole rats. FASEB J 19: 307-309.
26. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
27. Kirito K, Fox N, Komatsu N, Kaushansky K (2005) Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha. Blood 105: 4258-4263.
28. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, et al. (2005) Granulocyte colonystimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 19: 2005-2007.
29. Varney ML, Olsen KJ, Mosley RL, Singh RK (2005) Paracrine regulation of vascular endothelial growth factor-a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J Interferon Cytokine Res 25: 674-683.
30. Fujii K, Ishimaru F, Kozuka T, Matsuo K, Nakase K, et al. (2004) Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factorinduced peripheral blood stem cell mobilization. Br J Haematol 124: 190-194.
31. Bath PM, Sprigg N (2007) Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst Rev: CD005207.
32. Ieda Y, Fujita J, Ieda M, Yagi T, Kawada H, et al. (2007) G-CSF and HGF: combination of vasculogenesis and angiogenesis synergistically improves recovery in murine hind limb ischemia. J Mol Cell Cardiol 42: 540-548.
33. Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, et al. (2006) Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113: 701-710.
34. Tan Y, Shao H, Eton D, Yang Z, Alonso-Diaz L, et al. (2007) Stromal cellderived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovasc Res 73: 823-832.
35. Sehara Y, Hayashi T, Deguchi K, Zhang H, Tsuchiya A, et al. (2007) G-CSF enhances stem cell proliferation in rat hippocampus after transient middle cerebral artery occlusion. Neurosci Lett 418: 248-252.
36. Shingo T, Sorokan ST, Shimazaki T, Weiss S (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21: 9733-9743.
37. Wang L, Zhang Z, Zhang R, Hafner MS, Wong HK, et al. (2004) Erythropoietin up-regulates SOCS2 in neuronal progenitor cells derived from SVZ of adult rat. Neuroreport 15: 1225-1229.
38. Wang L, Zhang ZG, Zhang RL, Jiao ZX, Wang Y, et al. (2006) Neurogenin 1 mediates erythropoietin enhanced differentiation of adult neural progenitor cells. J Cereb Blood Flow Metab 26: 556-564.
39. Zhao LR, Singhal S, Duan WM, Mehta J, Kessler JA (2007) Brain repair by hematopoietic growth factors in a rat model of stroke. Stroke 38: 2584-2591.
40. Veschini L, Belloni D, Foglieni C, Cangi MG, Ferrarini M, et al. (2007) Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib. Blood 109: 2565-2570.
41. Dai Y, Xu M, Wang Y, Pasha Z, Li T, et al. (2007) HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 42: 1036-1044.
42. Shyu WC, Lin SZ, Chiang MF, Chen DC, Su CY, et al. (2008) Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J Clin Invest 118: 133-148.
43. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, et al. (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198:1391-1402.
44. Huang LE, Pete EA, Schau M, Milligan J, Gu J (2002) Leu-574 of HIF-1alpha is essential for the von Hippel-Lindau (VHL)-mediated degradation pathway. J Biol Chem 277: 41750-41755.
45. Huang LE, Arany Z, Livingston DM, Bunn HF (1996) Activation of hypoxiainducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271: 32253-32259.
46. Franklin TB, Perrot-Sinal TS (2006) Sex and ovarian steroids modulate brainderived neurotrophic factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions. Psychoneuroendocrinology 31: 38-48.
47. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, et al. (2000) Hypoxiainducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015.
48. Li Y, Lu Z, Keogh CL, Yu SP, Wei L (2007) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 27: 1043-1054.
49. Hess DC, Hill WD, Martin-Studdard A, Carroll J, Brailer J, et al. (2002) Bone marrow as a source of endothelial cells and NeuN-expressing cells After stroke. Stroke 33: 1362-1368.
50. Sawamoto K, Nakao N, Kakishita K, Ogawa Y, Toyama Y, et al. (2001) Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. J Neurosci 21: 3895-3903.
51. Park L, Anrather J, Zhou P, Frys K, Pitstick R, et al. (2005) NADPH-oxidasederived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25: 1769-1777.
52. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.